PMD Solutions Ltd, in partnership with Beaumont Hospital, Dublin, is undertaking a space-enabled medical solution “CORONA-RS” - to scale community monitoring of respiratory compromised patients in the community due to Covid-19 and other respiratory compromised patient cohorts.
Ms Sandy Rolfe (Respiratory Nurse Specialist, NHS Tayside) recently wrote for the British Journal of Nursing about ‘The importance of respiratory rate monitoring.’ This is the process undertaken by clinical staff of manually counting a patients’ breaths for one minute and recording that figure in the patients’ notes, along with their other vital signs. Rolfe highlights the reasons why respiratory monitoring is so important, how it can sometimes fall foul of inaccuracy and how it could be improved.
Topics: Respiratory Monitoring
THE BREATHING OF 40 COVID-19 PATIENTS IN BEAUMONT HOSPITAL IN DUBLIN IS BEING CONTINUOUSLY, REMOTELY MONITORED WITH RESPIRASENSE.
Now more than ever, healthcare providers around the world are being called upon to help bring better outcomes to every patient. Since 2011, PMD Solutions have been developing a solution: RespiraSense – a Continuous Respiratory Rate Monitor which can remotely monitor the breathing of multiple patients, simultaneously. RespiraSense has an error rate of just plus or minus one breath and is also the first device that can monitor breathing remotely.
One of the main advantages when interacting with patients with Coronavirus for healthcare providers using RespiraSense is that they don’t have to keep donning Personal Protective Equipment (PPE) to monitor the breathing of COVID-19 patients.
Two RespiraSense™ Clinical Research Posters, on the efficacy of respiratory rate monitoring, developed in collaboration with our centre of excellence will be on show in Belfast on Thursday, 24th and Friday, 25th January as part of the BOMMS Scientific Meeting.
PMD Solutions, an industry-leading medical technology company based in Cork, Ireland, today announced the issuance of Japanese Patent No. 6401718 Titled “A Method and Device for Respiratory Monitoring” issued September 14, 2018.
UCLPartners is supporting four trusts to take part in the set-up phase for a pilot of PMD Solutions’ RespiraSense™, the world’s only continuous and motion-tolerant respiratory rate monitor.
Frost & Sullivan awards PMD Solutions with the 2018 Visionary Innovation Leadership award for the non-invasive respiratory market at the Best Practices banquet in London. Best practice companies lead the way and set the example for others. The Best Practices Awards have identified exemplary achievements within a multitude of industries and functional disciplines for the last 18 years. Frost & Sullivan conducts best practices research to properly identify unrivalled innovation and leadership among companies, products, processes and executives.
Leading provider of respiratory monitoring technology, PMD Solutions saw outstanding success at this year’s MEDICA event. Showcasing its revolutionary RespiraSense™ product, the high growth early stage medical device company was invited by Enterprise Ireland to be part of the Irish pavilion where they were represented on a world stage among some of the globes leading Medtec organisations.
PMD Solutions, an industry-leading medical technology company based in Cork Ireland, today announced its successful enrolment in the NHS Innovation Accelerator (NIA) Programme as part of the NIA’s official kick-off launch event which took place in London this week.
SBRI Healthcare, the small Business Research Initiative for Healthcare (SBRI Healthcare), is an NHS England Initiative, led by the country’s 15 Academic Health Science Networks (AHSNs). Its role is to promote UK economic growth by spreading innovation and best practice across the NHS. Winners receive fully funded development contracts between the awarded company and NHS England to meet known healthcare needs.